Journal title Canadian Oncology Today. |
Frequency 3 issues per year (March, June, October) |
Archives
-
Volume 2, Issue 1, Spring 2025
- The Role of ctDNA in Breast Cancer: Prognosis and Clinical Utility
- Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?
- Current Approaches and Future Directions for the Treatment of Solid Tumour Brain Metastases
- The Role of Biomarkers in Upper Gastrointestinal Cancers
- Advances in Adjuvant Therapy for High-Risk Breast Cancer: A Canadian Clinical Approach
-
Volume 1, Issue 3, Fall 2024
- First-line Treatment Selection for Advanced Hepatocellular Carcinoma
- Prostate-specific Membrane Antigen (PSMA): A Diagnostic and Therapeutic Target in Advanced Prostate Cancer
- Breast Cancer Survivorship
- Tailored Approaches and Patient-centered Care: The Current Landscape of Neoadjuvant Therapy in Rectal Cancer
- Antibody-Drug Conjugates in the Management of Advanced Urothelial Carcinoma
-
Volume 1, Issue 2, Summer 2024
- Current and Emerging Treatment Options for HER2-Positive Gastroesophageal Cancer
- Current Uses and Pitfalls of Liquid Biopsy in NSCLC
- From Intractable to Treatable: Milestones and Horizons in the Management of HER2+ Breast Cancer
- Survivorship Issues in Testicular Cancer
- An Evolving Paradigm in Borderline Resectable and Locally Advanced Pancreatic Cancer: Current Strategies and Opportunities for the Future
-
Volume 1, Issue 1, March 2024
- The Evolution of PARP Inhibitors in Prostate Cancer
- KRAS Inhibitors in Lung Cancer: Current Strategies and Future Approaches
- Early Age Onset Colorectal Cancer: A Canadian Perspective
- Revolutionizing Breast Imaging: Artificial Intelligence’s Role in Precisely Differentiating Benign from Malignant Lesions
- A Review of EGFR-Mutant Non‑Small Cell Lung Cancer (NSCLC) in 2024